EMA CHMP recommends Moderna's Covid-19 booster for children – Pharmaceutical Technology

A Phase II/III trial of mRNA-1273.214 as a booster and initial regimen in children aged six months to five years is progressing.The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended granting variation to the marketing authorization (MA) for Moderna’s Spikevax bivalent Original/Omicron BA.1 (mRNA-1273.214) booster for usage in children aged […]

Continue reading

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years — United … – CDC

Weekly / November 4, 2022 / 71(44);1401–1406 Anne M. Hause, PhD1; Paige Marquez, MSPH1; Bicheng Zhang, MS1; Tanya R. Myers, PhD1; Julianne Gee, MPH1; John R. Su, MD, PhD1; Phillip G. Blanc, MD2; Alisha Thomas, MD2; Deborah Thompson, MD2; Tom T. Shimabukuro, MD1; David K. Shay, MD1 (View author affiliations)What is already known about this […]

Continue reading
1 38 39 40 41 42 94